Turkey: Food and Drugs Law

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Criminal And Legal Consequences Of Adulteration And Imitation In Food Supplements
Acts of adulteration and imitation concerning food supplements can trigger criminal, administrative, and civil liability beyond mere violations of food legislation. This examination explores the regulatory framework, the critical distinction between imitation and adulteration, applicable sanctions, and relevant Court of Cassation decisions that shape legal implications for product safety, consumer health, and trademark protection.
Turkey Consumer
C
CBC Law Firm
Article
Latest Development Regarding Medicinal Product Names – Guideline Regarding The Naming Of Medicinal Products For Human Use Has Been Published
Turkey's pharmaceutical regulatory landscape has evolved with new naming guidelines for human medicinal products. The Turkish Medicines and Medical Devices Agency has established comprehensive procedures for assessing product name similarity, incorporating INN root analysis and automated screening systems. These regulations introduce structured evaluation criteria and appeal mechanisms that will reshape how pharmaceutical companies approach product naming in the Turkish market.
Turkey Healthcare
G+
Gun + Partners
Article
İlaç İsimlerine İlişkin Güncel Gelişme - Beşeri Tıbbi Ürünlerin İsimlendirmesine Dair Kılavuz Yayımlandı
Turkey's Pharmaceutical and Medical Devices Agency has published new guidelines establishing comprehensive naming standards for medicinal products, introducing systematic evaluation criteria and procedures for assessing name similarity and acceptability. The guidelines implement a scoring system through TIBAS that compares proposed names against existing databases, while also addressing international nonproprietary name conflicts and promotional language restrictions.
Turkey Healthcare
G+
Gun + Partners
Article
Bitkisel temelli tıbbi ürünler, özel tıbbi amaçlı gıdalar ve tıbbi cihazlara ilişkin yenilikler
Turkey has introduced comprehensive new regulations governing aromatherapeutic products, medicinal herbal teas, traditional herbal medicinal products, and special medical purpose foods, establishing detailed licensing requirements and market authorization procedures. The regulations impose significant obligations on manufacturers, distributors, and retailers regarding electronic tracking systems, packaging standards, and promotional activities, while also introducing new restrictions on contact lens sales t
Turkey Healthcare
P
Paksoy
Article
Infringement Of Second Medical Use Claims And Proof Of Infringement
European and Turkish courts are reshaping how second medical use patent infringement is determined, moving beyond simple SmPC carve-outs to examine real-world prescribing patterns and market behavior. Recent landmark decisions establish that generic pharmaceutical companies may face liability even when patent-protected indications are removed from product documentation, if off-label or cross-label use occurs to a sufficient extent. The evolving legal framework now requires courts to assess both objective ma
Turkey IP
G+
Gun + Partners
Article
Pazara Erişim – Alternatif Geri Ödeme Modelleri
Turkey's alternative reimbursement models enable innovative pharmaceuticals to be covered outside standard pricing rules, allowing the Social Security Institution to negotiate discount rates and budget caps. A new initiative launching in January 2027 will systematically produce real-world clinical data and pharmacoeconomic evaluations for named patient program products to strengthen evidence-based reimbursement decisions.
Turkey Healthcare
G+
Gun + Partners
Article
Sağlık Meslek Mensupları ile Etkileşimler, Değer Aktarımları ve Ödeme Koşulları
Life sciences companies in Turkey navigate a complex regulatory framework governing interactions with healthcare professionals, where promotional activities face strict oversight and compliance expectations continue to intensify. While pharmaceutical promotion remains limited to healthcare professionals with mandatory transparency reporting, medical device regulations show signs of convergence in enforcement practices.
Turkey Healthcare
G+
Gun + Partners
See more